Peretsman, Samuel J. http://orcid.org/0000-0002-9211-3680
Emberton, Mark http://orcid.org/0000-0003-4230-0338
Fleshner, Neil http://orcid.org/0000-0001-7407-7463
Shoji, Sunao http://orcid.org/0000-0001-6673-9316
Bahler, Clinton D. http://orcid.org/0000-0003-0484-801X
Miller, Larry E. http://orcid.org/0000-0003-1594-1885
Funding for this research was provided by:
Sonablate
Article History
Received: 23 September 2023
Accepted: 16 January 2024
First Online: 20 March 2024
Declarations
:
: S. Peretsman reports employment with Sonablate. M Emberton serves as a consultant, investigator, and proctor/educator for Sonacare Inc and Angiodynamics Inc. Neil Fleshner reports no conflicts of interest. Sunao Shoji reports no conflicts of interest. C. Bahler reports consultancy with Sonablate, Telix Pharma, and Early is Good. L. Miller received research support from Sonablate.
: This research did not involve human participants or animals.
: Informed consent was not applicable, since this was a review of published studies.